S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Operating Income Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Operating Income
â‚©27B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Operating Income
â‚©1.3T
CAGR 3-Years
50%
CAGR 5-Years
29%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Operating Income
-â‚©8.7B
CAGR 3-Years
-14%
CAGR 5-Years
6%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Operating Income
-â‚©53.7B
CAGR 3-Years
3%
CAGR 5-Years
-16%
CAGR 10-Years
-22%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Operating Income
-â‚©18.3B
CAGR 3-Years
3%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Operating Income
-â‚©11.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Operating Income?
Operating Income
27B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Operating Income amounts to 27B KRW.

What is ST Pharm Co Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
41%

Over the last year, the Operating Income growth was 41%.

Back to Top